GLWL Research, Inc.
๐จ๐ฆCanada
- Country
- ๐จ๐ฆCanada
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://glwlresearch.com
A Study of GLWL-01 in Patients With Prader-Willi Syndrome
- First Posted Date
- 2017-09-07
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- GLWL Research Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT03274856
- Locations
- ๐บ๐ธ
Vanderbilt University, Nashville, Tennessee, United States
๐จ๐ฆCRCHUM, Montreal, Quebec, Canada
๐จ๐ฆAlberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01
Phase 1
Terminated
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: GLWL-01, Part CDrug: GLWL-01, Part ADrug: Placebo, Part ADrug: GLWL-01, Part BDrug: Placebo, Part BDrug: Placebo, Part C
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- GLWL Research Inc.
- Target Recruit Count
- 74
- Registration Number
- NCT02377362
- Locations
- ๐บ๐ธ
Celerion, Tempe, Arizona, United States
๐บ๐ธClinical Pharmacology of Miami, Inc., Miami, Florida, United States
๐บ๐ธProfil Institute for Clinical Research, Inc., Chula Vista, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath